Skip to content
Unrated Drug recall · FDA · Published March 15, 2019

Pfizer Cleocin Phosphate Injection Recall: Impurities Risk Serious Harm

Pfizer recalls Cleocin phosphate injection due to impurities that could cause serious harm. Patients with prescription orders should check their medication details and contact Pfizer for guidance.

🇺🇸 FDA recall #D-1069-2019DrugPfizer ›
Take action

Contact the company

Recalling firmPfizer Inc.235 E 42nd St · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer is recalling a specific clindamycin injection product due to impurities that could cause serious harm. This recall affects patients who have been prescribed this medication and requires them to check their medication details and contact Pfizer for guidance. Read more at govinfonow.com/recall/39080-pfizer-cleocin-phosphate-injection-recall-impurities-risk-serious-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/39080-pfizer-cleocin-phosphate-injection-recall-impurities-risk-serious-harm · Updated October 5, 2026 · FDA enforcement record: FDA #D-1069-2019

Cite this page

“Pfizer Cleocin Phosphate Injection Recall: Impurities Risk Serious Harm.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39080-pfizer-cleocin-phosphate-injection-recall-impurities-risk-serious-harm. Based on FDA recall #D-1069-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1069-2019%22&limit=1).

The FDA announced on March 15, 2019, that Pfizer Inc. voluntarily recalled Cleocin Phosphate injection due to failed impurity specifications. The recall affects products distributed by Pharmacia & Upjohn Co.

How to tell if you have it

  • Brand: Pfizer
  • Product: Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial
  • NDC: 0009-3447-01
  • Lot #: T78193
  • Expiration: 04/2019
  • Quantity: 500 cartons (25 vials per carton)

The hazard

The recall was issued because high out-of-specification results were demonstrated for several specified impurities at the 24-month time point. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Pfizer Inc. has 71 other recalls on record since November 26, 2012. Recent Pfizer recalls include an August 4, 2025 epinephrine vial recall for sterility risks and a July 10, 2025 Bicillin L-A suspension recall for particulate risks. Other recent recalls of similar products include a November 26, 2025 Sun Pharmaceutical clindamycin topical solution recall for impurities risk, a February 4, 2026 Somerset Therapeutics dexamethasone injection recall for impurity harm, and a November 13, 2025 Lupin ganirelix acetate injection recall for impurity risk.

How to tell if you have this one

Check for the product name 'Cleocin Phosphate', the strength '900 mg/6 mL', and the lot number 'T78193' on the vial. The expiration date is April 2019.

  • Brand
    Pfizer
  • Category
    Drug
FDA recall event · 6 products

All 6 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide USA and Guam
Recall numberProduct, codes & lotsQuantityNDC
D-1067-2019Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02; Lot #: T97469, Exp. 7/2019, W28574, Exp.09/201967 cartons (25 vials per carton)0009-0870-21, 0009-0870-26, 0009-0775-20, 0009-0775-26, 0009-0902-11, 0009-0902-18, 0009-0728-05, 0009-0728-09, 0009-3124-01, 0009-3124-03, 0009-3447-01, 0009-3447-03, 0009-3381-01, 0009-3381-02, 0009-3375-01, 0009-3375-02, 0009-3382-01, 0009-3382-02, 0009-6582-02, 0009-6582-01
D-1068-2019Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-3124-01; Lot#: T78191, Exp.04/2019, T97494, Exp.07/2019820 cartons (25 vials per carton)0009-0870-21, 0009-0870-26, 0009-0775-20, 0009-0775-26, 0009-0902-11, 0009-0902-18, 0009-0728-05, 0009-0728-09, 0009-3124-01, 0009-3124-03, 0009-3447-01, 0009-3447-03, 0009-3381-01, 0009-3381-02, 0009-3375-01, 0009-3375-02, 0009-3382-01, 0009-3382-02, 0009-6582-02, 0009-6582-01
D-1069-2019Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01; Lot #: T78193, Exp.04/2019500 cartons (25 vials per carton)0009-0870-21, 0009-0870-26, 0009-0775-20, 0009-0775-26, 0009-0902-11, 0009-0902-18, 0009-0728-05, 0009-0728-09, 0009-3124-01, 0009-3124-03, 0009-3447-01, 0009-3447-03, 0009-3381-01, 0009-3381-02, 0009-3375-01, 0009-3375-02, 0009-3382-01, 0009-3382-02, 0009-6582-02, 0009-6582-01
D-1070-2019Clindamycin Injection, USP, 300 mg/ 2 mL (150 mg/mL), 2 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA.,NDC 47781-619-94; Lot: T97472 (exp 07/2019), T97473 (exp 04/2019), W28573 (exp 09/2019), W31814 (exp 10/2019)701 cartons (25 vials per carton)—
D-1071-2019Clindamycin Injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC 47781-620-94; Lot #: T97496, Exp.04/2019, T97497, Exp.07/2019, W28564(exp 09/2019), W31812, Exp. 10/2019.8,878 cartons (25 vials per carton)—
D-1072-2019Clindamycin Injection, USP, 900 mg/6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA. NDC 47781-621-94; Lot #: T96398, Exp.07/2019, T97492, Exp.04/2019, W28567, Exp. 09/2019, W31813, Exp.10/20198,320 cartons (25 vials per carton)—
Based on the official FDA remedy

What to do — step by step

  1. Check Medication Details

    Look for the product name 'Cleocin Phosphate', strength '900 mg/6 mL', and lot number 'T78193' on the vial.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide USA and Guam” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.4 years after the firm started it.

1. Firm started the recall: Mar 15, 201912. FDA classified it Class III: Mar 29, 201923. Published in FDA’s Enforcement Report: Apr 10, 201934. FDA terminated the recall: Aug 11, 2022420192022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1069-2019 (March 15, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1069-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA